Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Decibel Cannabis CoDBCCD -0.60%75 Days Sales Outstanding is 68.19 as of Jun. 2026, which is 38% above its 10-year median of 49.55. GuruFocus rates DBCCD with a GF Score™ of 75/100 and a GF Value™ of $1.17 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 946 Drug Manufacturers companies, Decibel Cannabis Co ranks better than 61.42% on this metric.
The historical rank and industry rank for Decibel Cannabis Co's Days Sales Outstanding or its related term are showing as below:
DBCCD'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.59 Med: 49.55 Max: 66.74
Current: 61.06
During the past 13 years, Decibel Cannabis Co's highest Days Sales Outstanding was 66.74. The lowest was 24.59. And the median was 49.55.
DBCCD's Days Sales Outstanding is ranked better than 61.42% of 946
companies
in the Drug Manufacturers industry
Industry Median: 71.885
vs DBCCD: 61.06
Decibel Cannabis Co's Days Sales Outstanding
increased
from Jun. 2025 (41.02) to Jun. 2026 (68.19).
Decibel Cannabis Co (OTCPK:DBCCD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Decibel Cannabis Co Days Sales Outstanding Related Terms
Decibel Cannabis Co Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Decibel Cannabis Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Decibel Cannabis Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Decibel Cannabis Co Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Decibel Cannabis Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Decibel Cannabis Co's Days Sales Outstanding falls into.
Decibel Cannabis Co Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Decibel Cannabis Co (DBCCD) has a Days Sales Outstanding of 68.19 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Decibel Cannabis Co and its competitors. This is 38% above median its historical median of 49.55. Over the past decade, Decibel Cannabis Co's Days Sales Outstanding has ranged from 24.59 to 66.74. According to the industry distribution chart, Decibel Cannabis Co ranks #365 out of 946 companies in the Drug Manufacturers industry, placing it in the top 38.6%.
Is Decibel Cannabis Co's Days Sales Outstanding too high?
Decibel Cannabis Co's current Days Sales Outstanding of 68.19 is 38% above median its 10-year median of 49.55. Over the past 10 years, this metric has ranged from a low of 24.59 to a high of 66.74. The Drug Manufacturers industry median Days Sales Outstanding is 71.89. Decibel Cannabis Co's value of 68.19 is 5.1% below this industry median. Based on the distribution chart, Decibel Cannabis Co ranks #365 out of 946 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Decibel Cannabis Co has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Decibel Cannabis Co's Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Decibel Cannabis Co ranks #365 out of 946 companies for Days Sales Outstanding. This puts Decibel Cannabis Co in the upper half of its industry. The industry median Days Sales Outstanding is 71.89. Decibel Cannabis Co's value of 68.19 is 5.1% below this benchmark. Historically, Decibel Cannabis Co's own Days Sales Outstanding has ranged from 24.59 to 66.74 over the past decade. While the company's 10-year median is 49.55 vs. the industry median of 71.89, Decibel Cannabis Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.89, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Decibel Cannabis Co's current Days Sales Outstanding of 68.19 is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Decibel Cannabis Co and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Decibel Cannabis Co's current Days Sales Outstanding is 68.19, which is 38% above median its own 10-year median of 49.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Decibel Cannabis Co stock overvalued right now?
Based on GuruFocus' analysis, Decibel Cannabis Co (DBCCD) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.17, compared to a current price of $1.30 — trading 11.3% above its estimated fair value. The current Days Sales Outstanding is 68.19, which is 38% above median its 10-year median of 49.55 and 5.1% below the Drug Manufacturers industry median of 71.89. Decibel Cannabis Co's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Decibel Cannabis Co (DBCCD), the current Days Sales Outstanding is 68.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Decibel Cannabis Co (DBCCD) Overvalued in 2026?
Based on GuruFocus' analysis, Decibel Cannabis Co stock appears to be overvalued.
The current stock price of $1.30 is trading 11.3% above its estimated GF Value™ of $1.17.
GuruFocus considers Decibel Cannabis Co to be Modestly Overvalued.
Key valuation signals for DBCCD:
Days Sales Outstanding: 68.19 (38% above median its 10-year median of 49.55)
GF Value™: $1.17 vs. price of $1.30 (11.3% above fair value)
Industry Position: 5.1% below the Drug Manufacturers median (#365 of 946)
No single metric tells the full story. See the DBCCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Decibel Cannabis Co Inc is engaged in the cannabis operations business. The company is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers and the direct sale of products through its retailer locations to end customers.
75GF Score
Get the complete analysis for DBCCD
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DBCCD has been successfully added to your 
